Empresa Alpine Immune Sciences, Inc.
Acciones
ALPN
US02083G1004
Biotecnología e investigación médica
Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
64,56 USD | -0,09 % | +0,02 % | +238,72 % |
16/04 | ALPINE IMMUNE SCIENCES, INC. : Reducido a Neutral por TD Cowen | ZM |
12/04 | ALPINE IMMUNE SCIENCES, INC. : Leerink Partners es ahora neutral | ZM |
Resumen de negocios
Número de empleados: 142
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Protein-based Immunotherapies
100,0
%
| 30 | 100,0 % | 59 | 100,0 % | +95,84 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 30 | 100,0 % | 59 | 100,0 % | +95,84 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Mitchell Gold
CEO | Chief Executive Officer | 57 | 24/07/17 |
Director of Finance/CFO | - | 01/06/17 | |
Stanford Peng
PSD | President | 53 | 24/07/17 |
James Rickey
DFI | Director of Finance/CFO | 45 | 24/07/17 |
Christina Yi
CTO | Chief Tech/Sci/R&D Officer | 48 | 21/08/23 |
Wolfgang Dummer
CTO | Chief Tech/Sci/R&D Officer | 58 | 02/10/23 |
Temre Johnson
IRC | Investor Relations Contact | - | - |
Remy Durand
PRN | Corporate Officer/Principal | 38 | 01/01/18 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Robert Conway
BRD | Director/Board Member | 70 | 01/07/17 |
Mitchell Gold
CEO | Chief Executive Officer | 57 | 24/07/17 |
James Topper
BRD | Director/Board Member | 62 | 01/06/16 |
Peter Thompson
BRD | Director/Board Member | 64 | 01/06/16 |
Natasha Hernday
BRD | Director/Board Member | 52 | 10/12/20 |
Director/Board Member | 45 | 24/04/18 | |
Xiang Ming Cui
BRD | Director/Board Member | 55 | 18/01/19 |
Jörn Drappa
BRD | Director/Board Member | 60 | 18/07/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 65 546 136 | 62 501 628 ( 95,36 %) | 0 | 95,36 % |
Información de la empresa
Alpine Immune Sciences, Inc.
188 East Blaine Street Suite 200
98102, Seattle
+
http://www.alpineimmunesciences.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+238,72 % | 4235,35 M | |
-2,31 % | 103 mil M | |
+0,56 % | 95,28 mil M | |
+1,69 % | 22,15 mil M | |
-17,37 % | 21,02 mil M | |
-9,30 % | 18,15 mil M | |
-41,01 % | 16,73 mil M | |
-14,85 % | 16,05 mil M | |
+3,21 % | 13,68 mil M | |
+33,54 % | 12,17 mil M |
- Bolsa de valores
- Acciones
- Acción ALPN
- Empresa Alpine Immune Sciences, Inc.